Exact FDA event identifier

Event 89986

5 recalled-product records grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: April 21, 2022
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: McKesson Corporation dba McKesson Drug Company

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

5 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 5

Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-998-67

D-0847-2022

Recall number: D-0847-2022
Initiated: April 21, 2022
Classification: Class II
Status: Ongoing
Recalling firm: McKesson Corporation dba McKesson Drug Company
Quantity: 13, 200 tubes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Code information

Lots: 15720, Exp.: 06/30/2022; 16449 Exp.: 02/28/2023; 16450, Exp.: 02/26/2023

Distribution pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.

drug · product 2 of 5

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64

D-0848-2022

Recall number: D-0848-2022
Initiated: April 21, 2022
Classification: Class II
Status: Ongoing
Recalling firm: McKesson Corporation dba McKesson Drug Company
Quantity: 81,757 bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Code information

Lots: 15597, Exp.: 05/31/2023; 16305, Exp.: 12/23/2023; 16334, Exp.: 01/31/2024; 16340, Exp.: 01/31/2024; 16346 Exp.: 01/31/2024; 16356, Exp.: 01/31/2024; 16357, Exp.: 01/31/2024

Distribution pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.

drug · product 3 of 5

Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, NDC 63739-054-66

D-0849-2022

Recall number: D-0849-2022
Initiated: April 21, 2022
Classification: Class II
Status: Ongoing
Recalling firm: McKesson Corporation dba McKesson Drug Company
Quantity: 1176 tubes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Code information

Lot: 16876, Exp.: 05/31/2023

Distribution pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.

drug · product 4 of 5

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-65

D-0850-2022

Recall number: D-0850-2022
Initiated: April 21, 2022
Classification: Class II
Status: Ongoing
Recalling firm: McKesson Corporation dba McKesson Drug Company
Quantity: 55,440 tubes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Code information

Lot: 15644, Exp.: 05/31/2022

Distribution pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.

drug · product 5 of 5

Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-053-68

D-0851-2022

Recall number: D-0851-2022
Initiated: April 21, 2022
Classification: Class II
Status: Ongoing
Recalling firm: McKesson Corporation dba McKesson Drug Company
Quantity: 5,640 tubes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Code information

Lot: 15723, Exp.: 06/30/2022

Distribution pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.